NCT00266656View on ClinicalTrials.gov

Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Turner Syndrome
Interventions
DRUG

Humatrope

According to investigator's clinical practice and guided by the approved package insert

Trial Locations (9)

19107

Thomas Jefferson University, Philadelphia

27514

University of NC at Chapel Hill School of Medicine, Chapel Hill

46202

Riley Hosptial for Children, Indianapolis

60611

Children's Hospital of Chicago Research Center, Chicago

64108

Children's Mercy Hospital, Kansas City

80045

Children's Hospital, Aurora

90027

Childrens Hospital of Los Angeles, Los Angeles

98105

Childrens Hospital and Medical Center, Seattle

06106

Connecticut Children's Medical Center, Hartford

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00266656 - Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome | Biotech Hunter | Biotech Hunter